# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-045859
Filing Date
2024-11-14
Accepted
2024-11-14 16:10:37
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 951509
2 |  | ex10-1.htm | EX-10.1 | 309991
3 |  | ex31-1.htm | EX-31.1 | 11278
4 |  | ex31-2.htm | EX-31.2 | 11606
5 |  | ex32-1.htm | EX-32.1 | 11294
6 |  | ex10-1_001.jpg | GRAPHIC | 37951
7 |  | ex10-1_002.jpg | GRAPHIC | 73521
| Complete submission text file | 0001493152-24-045859.txt |  | 5296061

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | envb-20240930.xsd | EX-101.SCH | 41906
9 | XBRL CALCULATION FILE | envb-20240930_cal.xml | EX-101.CAL | 53581
10 | XBRL DEFINITION FILE | envb-20240930_def.xml | EX-101.DEF | 135326
11 | XBRL LABEL FILE | envb-20240930_lab.xml | EX-101.LAB | 348357
12 | XBRL PRESENTATION FILE | envb-20240930_pre.xml | EX-101.PRE | 254513
65 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 669458

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 241462219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)